DYAZIDE
- Product NDC
- 65084-135
- 11-digit product format
- 650840135
- Labeler code
- 65084
- Product ID
- 65084-135_a0053182-dd25-4095-baa2-6683b4cd7b95
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- hydrochlorothiazide and triamterene
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Mckesson Rxpak Inc
- Application
- NDA016042
- Marketing category
- NDA
- Marketing start
- 1994-03-30
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 65084-135 | | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 65084-135 | 65084-135-10 | D | Discontinued by firm | | 2026-07-31 |
Orange Book products#
Application-product, Trade name, Ingredient table| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|
| N016042-002 | DYAZIDE | HYDROCHLOROTHIAZIDE; TRIAMTERENE | 25MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | | Approved before 1982 | |
| N016042-003 | DYAZIDE | HYDROCHLOROTHIAZIDE; TRIAMTERENE | 25MG;37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | | RLD | 1994-03-03 |